Who owns Pds Biotechnology Ord?
- Ticker: PDSB
- CUSIP Number: 70465t107
Tip: Access positions for across all investors
Analyze quarterly positions in Pds Biotechnology Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pds Biotechnology Ord stock
Who bought or sold Pds Biotechnology Ord this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.9M | $1.9M | -3% | Sep 2025 |
|
| BlackRock | 518k | $523k | 1% | Sep 2025 |
|
| Geode Capital Management | 482k | $487k | 15% | Sep 2025 |
|
| Citadel Advisors | 415k | $419k | 34% | Sep 2025 |
|
| Integrys Wealth Advisors | 344k | $1.3M | 339% | Sep 2025 |
|
| Squarepoint Ops | 292k | $295k | 116% | Sep 2025 |
|
| Renaissance Technologies | 276k | $279k | 161% | Sep 2025 |
|
| William Blair $ Company | 250k | $253k | 0% | Sep 2025 |
|
| Caption Management | 219k | $221k | 100% | Sep 2025 |
|
| UBS Group | 200k | $202k | -63% | Sep 2025 |
|
| State Street Corporation | 133k | $135k | 0% | Sep 2025 |
|
| Northern Trust | 114k | $115k | -7% | Sep 2025 |
|
| Susquehanna International | 94k | $95k | 604% | Sep 2025 |
|
| Commonwealth Equity Services | 91k | $91k | 0% | Sep 2025 |
|
| Amussen Hunsaker & Associates | 75k | $77k | 100% | Sep 2025 |
|
| Acadian Asset Management | 62k | $61k | 100% | Sep 2025 |
|
| Watts Gwilliam & Co | 55k | $56k | 0% | Sep 2025 |
|
| Tempus Wealth Planning | 48k | $48k | 0% | Sep 2025 |
|
| Jane Street | 37k | $37k | -47% | Sep 2025 |
|
| Rockefeller Capital Management | 35k | $35k | 100% | Sep 2025 |
|
| Bank of New York Mellon | 29k | $30k | 0% | Sep 2025 |
|
| XTX Topco | 20k | $20k | 100% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 19k | $19k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 18k | $19k | 0% | Sep 2025 |
|
| First Manhattan | 15k | $15k | 0% | Sep 2025 |
|
| Two Sigma Securities | 14k | $14k | -37% | Sep 2025 |
|
| Raymond James Financial | 14k | $14k | -1% | Sep 2025 |
|
| Wealth Group | 13k | $18k | -13% | Jun 2025 |
|
| Mercer Global Advisors | 13k | $13k | 0% | Sep 2025 |
|
| Simplex Trading | 12k | $12k | 100% | Sep 2025 |
|
| Stratos Wealth Partners | 11k | $11k | 0% | Sep 2025 |
|
| Baader Bank | 11k | $6.6k | 100% | Sep 2025 |
|
| J.W. Burns & Company | 10k | $10k | 0% | Sep 2025 |
|
| Grandfield & Dodd | 10k | $10k | 0% | Sep 2025 |
|
| Morgan Stanley | 7.4k | $9.9k | 100% | Jun 2025 |
|
| Kathleen S. Wright Associates | 7.0k | $7.1k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 5.3k | $5.4k | 0% | Sep 2025 |
|
| Creative Financial Designs | 3.0k | $3.0k | 0% | Sep 2025 |
|
| Jones Financial Companies, L.L | 2.0k | $2.0k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 1.9k | $2.1k | -74% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.1k | $1.1k | 0% | Sep 2025 |
|
| FMR | 1.0k | $1.0k | -2% | Sep 2025 |
|
| Truvestments Capital | 655.00 | $662.008500 | -41% | Sep 2025 |
|
| Jpmorgan Chase & Co | 619.00 | $625.004300 | 0% | Sep 2025 |
|
| Rialto Wealth Management | 400.00 | $404.000000 | 0% | Sep 2025 |
|
| SBI Securities | 110.00 | $111.001000 | -47% | Sep 2025 |
|
| Advisor Group Holdings | 17.00 | $17.000000 | -97% | Sep 2025 |
|
Who sold out of Pds Biotechnology Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 81k | $108k |
| Marshall Wace | Jun 2025 | 69k | $91k |
| Virtu Financial | Jun 2025 | 32k | $43k |
| Marex Group | Jun 2025 | 14k | $19k |
| JustInvest | Jun 2025 | 14k | $19k |
| Sandbox Financial Partners | Jun 2025 | 13k | $17k |
| Cubist Systematic Strategies | Jun 2025 | 11k | $14k |
| Ronald Blue Trust | Jun 2025 | 4.5k | $6.0k |
| Tower Research Capital | Jun 2025 | 2.0k | $2.7k |
| Rise Advisors | Jun 2025 | 840.00 | $1.1k |
| Point72 | Jun 2025 | 50.00 | $66.000000 |